Jia-Qiang Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jia-Qiang Zhou has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Fei-Juan Kong
Department of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Department of Anesthesiology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, China
1 shared publication- Fei-Juan Kong
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Hong-Hai Zhang
Department of Anesthesiology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, China
1 shared publication- Hui-Shun Lu
Department of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
1 shared publication Lei-Lei Ma
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China
1 shared publication- Lei-Lei Ma
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 28 October 2016
- Published by Springer Nature in Nutrition Journal
- Vol. 15 (1) , 1-10
Serum selenium level and gestational diabetes mellitus: a systematic review and meta-analysis
The association between serum selenium level and gestational diabetes mellitus (GDM) is controversial. The aim of our study was to systematically review available literature linking selenium to GDM for a comprehensive understanding of the relationship between serum selenium level and GDM in human. PubMed, The Cochrane Library and Medline were searched for studies published up to August 2016. Manual searches of references of the relevant original studies were carried out. Pooled estimates were measured using the fixed or random effect model. Overall effect was reported in a standard mean difference (SMD). All data were analyzed with Review Manager 5.3 and Stata 12.0. Of 44 references reviewed, seven studies involving 569 patients met our inclusion criteria and contributed to meta-analysis. All the studies were used to evaluate the relationship between serum selenium level and GDM. Selenium level was significantly lower in women with GDM than those without GDM (SMD = −1.17; 95 % CI: −1.98 to −0.35, P = 0.005). Subgroup analysis showed that such trend was consistent within the non-Caucasian population (Asia: SMD = −2.82; 95 % CI: −5.21 to −0.43, P = 0.02; Africa: SMD = −0.56; 95 % CI: −1.07 to −0.05, P = 0.03) and in the third trimester (SMD = −1.78; 95 % CI: −3.04 to −0.52, P = 0.006), but not within the Caucasian population (Europe: SMD = −0.6; 95 % CI: −1.98 to 0.78, P = 0.39) or in the second trimester (SMD = −0.68; 95 % CI: −1.6 to 0.25, P = 0.15). The available evidences suggested that serum selenium level was lower in women with GDM than those with normal glucose tolerance, especially within the non-Caucasian population and in the third trimester. However, well-designed prospective studies are needed to understand dynamic associations between selenium status and GDM risk.
- 28 October 2016
- Published by Springer Nature in Nutrition Journal
- Vol. 15 (1) , 1-10
Open AccessSerum selenium level and gestational diabetes mellitus: a systematic review and meta-analysis
The association between serum selenium level and gestational diabetes mellitus (GDM) is controversial. The aim of our study was to systematically review available literature linking selenium to GDM for a comprehensive understanding of the relationship between serum selenium level and GDM in human. PubMed, The Cochrane Library and Medline were searched for studies published up to August 2016. Manual searches of references of the relevant original studies were carried out. Pooled estimates were measured using the fixed or random effect model. Overall effect was reported in a standard mean difference (SMD). All data were analyzed with Review Manager 5.3 and Stata 12.0. Of 44 references reviewed, seven studies involving 569 patients met our inclusion criteria and contributed to meta-analysis. All the studies were used to evaluate the relationship between serum selenium level and GDM. Selenium level was significantly lower in women with GDM than those without GDM (SMD = −1.17; 95 % CI: −1.98 to −0.35, P = 0.005). Subgroup analysis showed that such trend was consistent within the non-Caucasian population (Asia: SMD = −2.82; 95 % CI: −5.21 to −0.43, P = 0.02; Africa: SMD = −0.56; 95 % CI: −1.07 to −0.05, P = 0.03) and in the third trimester (SMD = −1.78; 95 % CI: −3.04 to −0.52, P = 0.006), but not within the Caucasian population (Europe: SMD = −0.6; 95 % CI: −1.98 to 0.78, P = 0.39) or in the second trimester (SMD = −0.68; 95 % CI: −1.6 to 0.25, P = 0.15). The available evidences suggested that serum selenium level was lower in women with GDM than those with normal glucose tolerance, especially within the non-Caucasian population and in the third trimester. However, well-designed prospective studies are needed to understand dynamic associations between selenium status and GDM risk.
- 1 March 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 194 (1) , 255-261
Alpha 7 nicotinic acetylcholine receptor agonist GTS-21 mitigates isoflurane-induced cognitive impairment in aged rats
- 1 March 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 194 (1) , 255-261
Alpha 7 nicotinic acetylcholine receptor agonist GTS-21 mitigates isoflurane-induced cognitive impairment in aged rats